Immunex Corporation

Type: Company
Name: Immunex Corporation
Nationality: United States
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Dermatological Drugs Market Forecast 2014-2024

/PRNewswire/ -- Future Prospects for Leading CompaniesDermatological drugs - new study showing you trends, R&D progress, and predicted revenues Where's the dermatological drugs market heading [https://www.visiongain.com/Report/1242/Dermatological-Drugs-Market-Forecast-2014-2024 ... [Published Individual.com - 23 hours ago]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Western PA colleges schedule commencement

Published: Monday, April 21, 2014 11:18 p.m.Updated less than a minute agoCommencement season for the Class of 2014 begins soon and will continue through May for colleges and universities in Western Pennsylvania.• Butler County Community College, 7 p.m. ... [Published Pittsburgh Tribune Review - Apr 22 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Biotech firms, investors biding time for breakthrough drugs

Windsor Genova – Fourth Estate Cooperative ContributorNew York, NY, United States (4E) – Many biotech firms are now biding their time, waiting for their research projects to result in a breakthrough drug that will not only cure a once untreatable disease ... [Published GantDaily.com - Apr 14 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Maker of Candy Crush Saga Buckles on Its First Day of Trading

c.2014 New York Times News ServiceCandy Crush Saga has been a smash hit, attracting tens of millions of players and generating spectacular profits for its developer, King Digital Entertainment.But Wednesday, when King had its debut on the New York Stock ... [Published Columbus - Mar 27 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Editorial: With T-Mobile at risk, do more to promote Seattle’s corporate culture

THE Seattle area is in danger of losing another corporate headquarters — never a positive development. During a swing through Washington, D.C., this month, Sprint Chairman Masayoshi Son made no secret of his lust for Bellevue-based telecom rival T-Mo ... [Published Seattle Times - Mar 24 2014]
First reported Mar 16 2014 - Updated Mar 16 2014 - 1 reports

Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof

The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in ... [Published PharmCast - Mar 16 2014]
First reported Feb 26 2014 - Updated Feb 26 2014 - 1 reports

Catalent Announces Two Senior Appointments to Expand Biologics Business

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced two senior appointments to further strengthen its global biologics business. ... [Published PRWeb - Feb 26 2014]
First reported Feb 12 2014 - Updated Feb 12 2014 - 1 reports

Tekmira appoints Phillips to board

Tekmira Pharmaceuticals Corp. has appointed Peggy Phillips to its board of directors."Peggy's appointment and expertise is consistent with our focus on product development. We're confident that her extensive biotechnology experience, senior executive ... [Published Stockwatch - Feb 12 2014]
First reported Dec 04 2013 - Updated Dec 04 2013 - 1 reports

Spangler receiver to return nearly half of investors money

Working at a booming biotech company in Seattle in the ’90s, Richard Boyd and his wife had more money than they knew what to do with.They both worked for Immunex, a biotechnology company now owned by Amgen, and received stock options as part of their ... [Published Seattle Times - Dec 04 2013]
First reported Dec 01 2013 - Updated Dec 01 2013 - 1 reports

Cell-permeabilising peptides and polypeptides for microbial cells

Signal peptides and polypeptides from Methanobrevibacter ruminantium, a methanogenic archaea present in ruminants. Methods of using these peptides to permeabilise microbial cells, particularly M. ruminantium strain M1.sup..tau. (DSM 1093).Description ... [Published PharmCast - Dec 01 2013]

Quotes

"Peggy's appointment and expertise is consistent with our focus on product development. We're confident that her extensive biotechnology experience, senior executive background and considerable drug development expertise will translate to valuable contributions to our board and company" said Dr. Mark J Murray, Tekmira's president and chief executive officer
...This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. "Fortunately for the millions of people now afflicted with stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel" said Dr. Rolando Hernandez M D
"Roche has come to the conclusion not to pursue Indian Patent No. 205534 (the secondary patent for Trastuzumab) and the related divisional applications. This decision takes into account the strength of the particular rights and the Intellectual Property environment in India in general" a spokesperson from Roche was quoted as saying by Indian publication The Economic Times
...This dose of minocycline is the same as that commonly used to treat adolescent acne. "The short term perispinal Enbrel (PSE) treatment we employ can be a real lifesaver for individuals with stroke who are suffering with depression. "Perispinal Enbrel as a TBI treatment has many attributes. (1) The therapeutic window is wide. A person who's stroke occurred a decade ago or even longer may still benefit. (2) The treatment is short term, involving just one to four injections over a period of up to forty days, yet the benefits are long lasting. (3) The dosage of Enbrel needed to achieve these results is quite low compared to the FDA recommendations for moderate plaque psoriasis. The FDA protocol for moderate plaque psoriasis calls for 24 injections, totaling 1200 mg of Enbrel over a three month period, followed by weekly injections for life. (4) The recovery can begin to occur in minutes and can build with subsequent injections over the course of treatment," stated Dr. Hernandez."

More Content

All (16) | News (14) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Dermatological Drugs Market Forecast 2014-2024 [Published Individual.com - 23 hours ago]
Western PA colleges schedule commencement [Published Pittsburgh Tribune Review - Apr 22 2014]
Biotech firms, investors biding time for breakt... [Published GantDaily.com - Apr 14 2014]
Maker of Candy Crush Saga Buckles on Its First ... [Published Columbus - Mar 27 2014]
Editorial: With T-Mobile at risk, do more to pr... [Published Seattle Times - Mar 24 2014]
Cloned transmembrane receptor for 24-hydroxylat... [Published PharmCast - Mar 16 2014]
Catalent Announces Two Senior Appointments to E... [Published PRWeb - Feb 26 2014]
Tekmira appoints Phillips to board [Published Stockwatch - Feb 12 2014]
2013: The year's biggest Pharmaceutical Technol... [Published Pharmaceutical Technology - Jan 08 2014]
Spangler receiver to return nearly half of inve... [Published Seattle Times - Dec 04 2013]
Cell-permeabilising peptides and polypeptides f... [Published PharmCast - Dec 01 2013]
New Stroke Treatment Enables People Who Have Be... [Published PRWeb - Oct 23 2013]
Strechforlife and Neurological Wellness Center ... [Published PRWeb - Sep 25 2013]
August's top stories: Novartis's MS drug invest... [Published Pharmaceutical Technology - Sep 02 2013]
Amgen planning to buy Onyx for about $10.4 billion [Published Topnews.in - Aug 26 2013]
Stroke Treatment Reduces Depression [Published PRWeb - Aug 14 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.